(Q29619886)
Statements
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial (English)
Laakso M
Heine RJ
Taton J
Dormandy JA
Charbonnel B
Eckland DJ
Erdmann E
Massi-Benedetti M
Moules IK
Skene AM
Tan MH
Lefèbvre PJ
Murray GD
Standl E
Wilcox RG
Wilhelmsen L
Betteridge J
Birkeland K
Golay A
Korányi L
Mokán M
Norkus A
Pirags V
Podar T
Scheen A
Scherbaum W
Schernthaner G
Schmitz O
Skrha J
Smith U
8 October 2005
366
1279-89
9493